53 related articles for article (PubMed ID: 6181870)
1. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
[TBL] [Abstract][Full Text] [Related]
2. Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
Massard C; Kramar A; Beyer J; Hartmann JT; Lorch A; Pico JL; Rosti G; Droz JP; Fizazi K
Ann Oncol; 2013 Feb; 24(2):322-328. PubMed ID: 23104726
[TBL] [Abstract][Full Text] [Related]
3. Monocyte chemotaxis in patients with nonseminomatous testicular carcinoma. Effect of chemotherapy.
Nielsen H; Rørth M; Bennedsen J
Cancer Immunol Immunother; 1985; 19(1):68-71. PubMed ID: 3844976
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic Hyperthyroidism Secondary to a Chemotherapy-Induced Surge in β-hCG in a Patient with Non-Seminomatous Germ Cell Tumor.
Erol LA; Layman CP
Hawaii J Health Soc Welf; 2024 Feb; 83(2):45-47. PubMed ID: 38344694
[TBL] [Abstract][Full Text] [Related]
5. 'FLARE' of tumor marker in advanced gastric cancer treated with first-line systemic therapy.
Zhang F; Zhai M; Yang J; Zhao L; Lin Z; Wang J; Zhang T; Yu D
Therap Adv Gastroenterol; 2022; 15():17562848221124029. PubMed ID: 36187367
[TBL] [Abstract][Full Text] [Related]
6. Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Chan SK; Chan SY; Choi HC; Tong CC; Lam KO; Kwong DL; Vardhanabhuti V; Leung TW; Luk MY; Lee AW; Lee VH
Front Oncol; 2020; 10():1417. PubMed ID: 32974150
[No Abstract] [Full Text] [Related]
7. The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.
Takizawa A; Kawai K; Kawahara T; Kojima T; Maruyama S; Shinohara N; Akamatsu S; Kamba T; Nakamura T; Ukimura O; Jikuya R; Kishida T; Kakimoto K; Nishimura K; Harabayashi T; Nagamori S; Yamashita S; Arai Y; Sawada Y; Sekido N; Kinoshita H; Matsuda T; Nakagawa T; Homma Y; Nishiyama H
J Cancer Res Clin Oncol; 2018 Jan; 144(1):109-115. PubMed ID: 28905168
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal Germ Cell Tumor Exhibiting a Discrepancy between Tumor Markers and Imaging: A Case Study.
Takenaka K; Mukohara T; Hirai C; Funakoshi Y; Nakamura Y; Chayahara N; Toyoda M; Kiyota N; Itoh T; Yokozaki H; Minami H
Case Rep Oncol; 2015; 8(2):323-31. PubMed ID: 26351441
[TBL] [Abstract][Full Text] [Related]
9. In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR).
Guldbrandsen A; Vethe H; Farag Y; Oveland E; Garberg H; Berle M; Myhr KM; Opsahl JA; Barsnes H; Berven FS
Mol Cell Proteomics; 2014 Nov; 13(11):3152-63. PubMed ID: 25038066
[TBL] [Abstract][Full Text] [Related]
10. Systemic dysregulation of CEACAM1 in melanoma patients.
Markel G; Ortenberg R; Seidman R; Sapoznik S; Koren-Morag N; Besser MJ; Bar J; Shapira R; Kubi A; Nardini G; Tessone A; Treves AJ; Winkler E; Orenstein A; Schachter J
Cancer Immunol Immunother; 2010 Feb; 59(2):215-30. PubMed ID: 19633846
[TBL] [Abstract][Full Text] [Related]
11. Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
Sell S
Tumour Biol; 2008; 29(3):161-80. PubMed ID: 18612221
[TBL] [Abstract][Full Text] [Related]
12. The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.
Xu X; Ke QH; Shao ZX; Wu J; Chen J; Zhou L; Zheng SS
Dig Dis Sci; 2009 Feb; 54(2):385-8. PubMed ID: 18563566
[TBL] [Abstract][Full Text] [Related]
13. Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors.
Kirch C; Blot F; Fizazi K; Raynard B; Theodore C; Nitenberg G
Support Care Cancer; 2003 Sep; 11(9):575-80. PubMed ID: 12783290
[TBL] [Abstract][Full Text] [Related]
14. Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.
de Wit R; Collette L; Sylvester R; de Mulder PH; Sleijfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Stoter G
Br J Cancer; 1998 Nov; 78(10):1350-5. PubMed ID: 9823978
[TBL] [Abstract][Full Text] [Related]
15. Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors.
Han SJ; Yoo S; Choi SH; Hwang EH
Pediatr Surg Int; 1997; 12(8):599-602. PubMed ID: 9354734
[TBL] [Abstract][Full Text] [Related]
16. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
17. Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?
Kattan J; Culine S; Tavakoli-Razavi T; Kramar A; Droz JP
Support Care Cancer; 1994 Mar; 2(2):128-31. PubMed ID: 7512416
[TBL] [Abstract][Full Text] [Related]
18. The detection and evaluation of human tumor metastases.
Laurence DJ; Neville AM
Cancer Metastasis Rev; 1983; 2(4):351-74. PubMed ID: 6203639
[TBL] [Abstract][Full Text] [Related]
19. The use and potential of serum tumour markers, new and old.
Bates SE
Drugs; 1989 Jul; 38(1):9-18. PubMed ID: 2670513
[No Abstract] [Full Text] [Related]
20. Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency.
Motzer RJ; Niedzwiecki D; Isaacs M; Menendez-Botet C; Tong WP; Flombaum C; Scher HI; Bosl GJ
Cancer Chemother Pharmacol; 1990; 27(3):234-8. PubMed ID: 2176133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
